Xylem (XYL) Cost of Revenue (2010 - 2026)

Xylem's Cost of Revenue history runs 17 years deep, the most recent figure standing at $1.3 billion for Q1 2026.

• In Q1 2026, Cost of Revenue rose 1.61% year-over-year to $1.3 billion; the TTM figure through Mar 2026 stood at $5.6 billion (up 3.93% YoY), while the FY2025 annual figure was $5.6 billion, up 3.93% from the prior year.
• Cost of Revenue was $1.3 billion for Q1 2026 at Xylem, down from $1.5 billion in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $1.5 billion in Q4 2025 to a low of $805.0 million in Q1 2022.
• Historically, Cost of Revenue has averaged $1.2 billion across 5 years, with a median of $1.3 billion in 2023.
• The sharpest annual moves came in 2023 and 2024: Cost of Revenue surged 53.27% in 2023, then rose 0.61% in 2024.
• A 5-year view of Cost of Revenue shows it stood at $933.0 million in 2022, then surged by 45.98% to $1.4 billion in 2023, then gained by 2.72% to $1.4 billion in 2024, then gained by 4.72% to $1.5 billion in 2025, then retreated by 9.76% to $1.3 billion in 2026.
• The last three Cost of Revenue figures came in at $1.3 billion (Q1 2026), $1.5 billion (Q4 2025), and $1.4 billion (Q3 2025), per Business Quant data.